logo
logo
Sign in

Cardiovascular Prosthetic Devices Market Projected to Gain Significant Value through 2032

avatar
Ganesh Shinde
Cardiovascular Prosthetic Devices Market Projected to Gain Significant Value through 2032

The global cardiovascular prosthetic devices market is estimated to be worth US$ 5.1 billion in 2021 and to grow at an 8.1% CAGR to US$ 11.9 billion by 2032.

The goal of cardiovascular prosthetic device development is to replace injured heart tissues. These devices are designed to perform similarly to regular cardiovascular systems. Cardiovascular prostheses have increased cardiac surgeons' ability to repair heart blockages. The two most frequent prosthesis are pacemakers and heart valves.

The growing prevalence of atrial septal defect (ASD) and valvular illness, rising rates of cardiovascular disease, and an ageing population are driving the demand for cardiovascular prosthetic devices. New technological breakthroughs and increasing adoption rates of these devices are expected to push the market throughout the forecast period.

Furthermore, an increase in the elderly population, a preference for minimally invasive procedures, technological advancements resulting in the development of effective devices, and an increase in obesity followed by continuous product development are expected to boost the market for cardiovascular prosthetic devices. Furthermore, the increased frequency of hypertension among people is expected to drive growth in the cardiovascular prosthetic market throughout the forecast period.

North American countries are likely to create the largest market for cardiovascular prosthetic devices in the projected years due to the high prevalence of cardiovascular ailments such as rheumatic diseases and valvular disorders and the growing demand for the devices.

Europe is also predicted to grow and gain a sizable market share. The market is likely to increase in the near future due to the rising prevalence of heart valve disease and irregular heart rhythm disorders, as well as the rapid adoption of upgraded prosthetic devices.

Key Players in the Cardiovascular Prosthetic Devices Market:

Some of the market players operating in the cardiovascular prosthetic devices market are Abbott Laboratories, Edwards Lifesciences Corporation., Medtroic Inc., W. L. Gore & Associates, Inc., Lifetech Scientific Co., Ltd., Abiomed, Inc., BIOTRONIK SE & Co. KG, Pacetronix, Meril Life Sciences Pvt. Ltd., Venus Medtech and others.

Read More@ https://www.futuremarketinsights.com/reports/cardiovascular-prosthetic-devices-market

Key Segments Covered in the Cardiovascular Prosthetic Devices Industry Survey

By Product:

  • Valves
  • Pacemakers

By Application:

  • Surgery
  • Research

By End User:

  • Hospitals
  • Cardiac Centers
  • Ambulatory Surgical Centers
  • Specialty Clinics


collect
0
avatar
Ganesh Shinde
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more